AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
AST market to reach $6.01B by 2030 as rapid diagnostics gain ground
AGP
The antimicrobial susceptibility testing market is projected to grow from $4.65 billion in 2025 to $6.01 billion by 2030, driven by infectious disease prevalence, antimicrobial resistance surveillance and demand for faster diagnostics.
AMR genotyping panels market seen reaching $2.81 billion by 2030
AGP
The market for antimicrobial resistance genotyping panels is projected to rise from $1.45 billion in 2025 to $2.81 billion by 2030, driven by growing resistant infections, faster molecular diagnostics and tighter resistance monitoring.
ANCA vasculitis market to hit $0.95 billion by 2030
AGP
The Business Research Company says the global ANCA-associated vasculitis market will rise from $0.63 billion in 2025 to $0.95 billion by 2030, driven by targeted biologics, better diagnostics and broader access to specialty care.
Antibody contract manufacturing market seen reaching $34.72 billion by 2030
AGP
The Business Research Company says the antibody contract manufacturing market will grow from $16.79 billion in 2025 to $19.32 billion in 2026, then climb to $34.72 billion by 2030. The report points to rising biologics pipelines, more clinical…
Antibodies market forecast to hit $666.72B by 2030
AGP
The Business Research Company says the global antibodies market will grow from $381.67 billion in 2026 to $666.72 billion by 2030, driven by biologic therapies, immunology research and rising autoimmune disease cases.
Alopecia market seen reaching $14.29 billion by 2030
AGP
The global alopecia market is projected to rise to $14.29 billion by 2030, up from $11.93 billion in 2026, as hair loss cases increase and treatment options widen.
Alpha-1 antitrypsin deficiency augmentation therapy market seen reaching $2.68 billion by 2030
AGP
The global market for alpha-1 antitrypsin deficiency augmentation therapy is projected to grow from $1.8 billion in 2025 to $2.68 billion by 2030, driven by clinical trials, gene-targeted therapies and new delivery methods.
Anti-snoring treatment market seen reaching $3.78 billion by 2030
AGP
The anti-snoring treatment market is projected to grow from $2.54 billion in 2025 to $3.78 billion by 2030, driven by sleep disorder prevalence, higher healthcare spending and wider access to devices and therapies.
Alopecia areata market seen reaching $5.72 billion by 2030
AGP
The Business Research Company says the global alopecia areata market will grow from $3.81 billion in 2025 to $5.72 billion by 2030, powered by new immunotherapy drugs, teledermatology and more clinical trials.
Aortic aneurysm market seen rising to $6.62 billion by 2030
AGP
The global aortic aneurysm market is projected to grow from $4.06 billion in 2025 to $6.62 billion by 2030, according to a new report from The Business Research Company.
Antiphospholipid syndrome treatment market seen reaching $88.91 billion by 2030
AGP
The antiphospholipid syndrome treatment market is projected to grow from $52.78 billion in 2025 to $88.91 billion by 2030, according to The Business Research Company.
Anemia in elderly market seen reaching $4.59 billion by 2030
AGP
The Business Research Company says the global anemia in elderly market is growing as aging populations expand and diagnosis improves.
Antibody production services market seen reaching $11.45 billion by 2030
AGP
The antibody production services market is projected to grow from $6.44 billion in 2025 to $7.24 billion in 2026, then climb to $11.45 billion by 2030. Demand is being driven by chronic disease prevalence, biologics pipelines, outsourcing by…
Allogeneic cell therapy market seen reaching $1.97 billion by 2030
AGP
The allogeneic cell therapy market is projected to grow from $1.2 billion in 2025 to $1.97 billion by 2030, according to The Business Research Company.
Anesthesia disposables market to reach $1.73 billion by 2030
AGP
The anesthesia circuits and regional anesthesia disposables market is projected to grow from $1.52 billion in 2025 to $1.73 billion by 2030, driven by more surgeries, wider use of disposable products and rising demand for safer anesthesia…
Antidiabetics market seen reaching $141.48 billion by 2030
AGP
The global antidiabetics market is projected to grow from $93.29 billion in 2026 to $141.48 billion by 2030, according to The Business Research Company.
Albumin and creatinine tests market seen doubling by 2030
AGP
The market for albumin and creatinine tests reached $3.6 billion in 2025 and is projected to rise to $9.65 billion by 2030, according to The Business Research Company.
Allergy immunotherapy market seen reaching $5.64 billion by 2030
AGP
The allergy immunotherapy market is projected to grow from $3.55 billion in 2026 to $5.64 billion by 2030, driven by rising allergic disease rates, more personalized treatments and wider access through online channels.
Alcoholic hepatitis treatment market seen reaching $5.26 billion by 2030
AGP
The alcoholic hepatitis treatment market is projected to grow from $3.43 billion in 2025 to $5.26 billion by 2030, driven by rising alcohol-related liver disease, wider use of corticosteroids and other therapies, and growing interest in stem cell…
Anterior uveitis market seen reaching $0.98 billion by 2030
AGP
The anterior uveitis market is projected to grow from $0.57 billion in 2025 to $0.98 billion by 2030, driven by rising autoimmune disease cases, better diagnostics and expanding biologic treatment options.
Sign up for:
Latin America News Hub
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.